نتایج جستجو برای: mycn

تعداد نتایج: 1228  

2012
Laura D. Gamble Michael D. Hogarty Xueyuan Liu David S. Ziegler Glenn Marshall Murray D. Norris Michelle Haber

Polyamines are highly regulated essential cations that are elevated in rapidly proliferating tissues, including diverse cancers. Expression analyses in neuroblastomas suggest that up-regulation of polyamine pro-synthetic enzymes and down-regulation of catabolic enzymes is associated with poor prognosis. Polyamine sufficiency may be required for MYCN oncogenicity in MYCN amplified neuroblastoma,...

2009
Seiki Haraguchi Akira Nakagawara

BACKGROUND The TH-MYCN transgenic mouse is the most widely used murine model of human neuroblastoma, in which a human MYCN oncogene is targeted to neuroectodermal cells of developing mice under the influence of the rat tyrosine hydroxylase promoter. So far, homozygous transgenic mice have been identified by either Southern blot or quantitative real-time PCR. PRINCIPAL FINDINGS To establish a ...

Journal: :Cold Spring Harbor perspectives in medicine 2013
Miller Huang William A Weiss

Neuroblastoma, the most common extracranial solid tumor of childhood, is thought to originate from undifferentiated neural crest cells. Amplification of the MYC family member, MYCN, is found in ∼25% of cases and correlates with high-risk disease and poor prognosis. Currently, amplification of MYCN remains the best-characterized genetic marker of risk in neuroblastoma. This article reviews roles...

Journal: :Cancer cell 2012
Shizhen Zhu Jeong-Soo Lee Feng Guo Jimann Shin Antonio R Perez-Atayde Jeffery L Kutok Scott J Rodig Donna S Neuberg Daniel Helman Hui Feng Rodney A Stewart Wenchao Wang Rani E George John P Kanki A Thomas Look

Amplification of the MYCN oncogene in childhood neuroblastoma is often accompanied by mutational activation of ALK (anaplastic lymphoma kinase), suggesting their pathogenic cooperation. We generated a transgenic zebrafish model of neuroblastoma in which MYCN-induced tumors arise from a subpopulation of neuroblasts that migrate into the adrenal medulla analog following organogenesis. Coexpressio...

2016
Jungoh Ham Carlotta Costa Renata Sano Timothy L. Lochmann Erin M. Sennott Neha U. Patel Anahita Dastur Maria Gomez-Caraballo Kateryna Krytska Aaron N. Hata Konstantinos V. Floros Mark T. Hughes Charles T. Jakubik Daniel A.R. Heisey Justin T. Ferrell Molly L. Bristol Ryan J. March Craig Yates Mark A. Hicks Wataru Nakajima Madhu Gowda Brad E. Windle Mikhail G. Dozmorov Mathew J. Garnett Ultan McDermott Hisashi Harada Shirley M. Taylor Iain M. Morgan Cyril H. Benes Jeffrey A. Engelman Yael P. Mossé Anthony C. Faber

Fewer than half of children with high-risk neuroblastoma survive. Many of these tumors harbor high-level amplification of MYCN, which correlates with poor disease outcome. Using data from our large drug screen we predicted, and subsequently demonstrated, that MYCN-amplified neuroblastomas are sensitive to the BCL-2 inhibitor ABT-199. This sensitivity occurs in part through low anti-apoptotic BC...

2006
Lothar Schweigerer Stephen Breit Achim Wenzel Kentaro Tsunamoto Rolf Ludwig Manfred Schwab

Amplification and enhanced expression of the MYCN oncogene are thought to contribute to the development and progression of human neuroblastomas. Here, we have transfected human neuroblastoma cells that harbor a single MYCN gene copy with the human MYCN gene driven by a viral enhancer/promoter, and we have compared the properties of the parental and the transfected cells. The transfected cells s...

Journal: :Cancer research 2011
Nunzio Iraci Daniel Diolaiti Antonella Papa Antonio Porro Emanuele Valli Samuele Gherardi Steffi Herold Martin Eilers Roberto Bernardoni Giuliano Della Valle Giovanni Perini

Neuroblastoma is the most common extracranial solid tumor of childhood. One important factor that predicts a favorable prognosis is the robust expression of the TRKA and p75NTR neurotrophin receptor genes. Interestingly, TRKA and p75NTR expression is often attenuated in aggressive MYCN-amplified tumors, suggesting a causal link between elevated MYCN activity and the transcriptional repression o...

2015
Romeil Sandhu Sarah Tannenbaum Daniel Diolaiti Alberto Ambesi-Impiombato Andrew Kung Allen Tannenbaum

The amplification of the gene MYCN (V-myc myelocytomatosis viral-valeted oncogene, neuroblastoma derived) has been a well-documented indicator for poor prognosis in neuroblastoma, a childhood cancer. Unfortunately, there has been limited success in understanding MYCN functionality in the landscape of neuroblastoma and more importantly, given that MYCN has been deemed “undruggable,” the need to ...

1999
Giuseppe Raschellà Vincenzo Cesi Roberto Amendola Anna Negroni Barbara Tanno Pierluigi Altavista Gian Paolo Tonini Bruno De Bernardi Bruno Calabretta

The transcription factors of the Myb family are expressed in several tissues and play an important role in cell proliferation, differentiation, and survival. In this study, the expression of A-myb, B-myb, and c-myb was investigated in a group of 64 neuroblastomas at different clinical stages by a sensitive reverse transcription-PCR technique and correlated with patients’ survival. All of the my...

2018
Jing Wang Siqi Huang Ruicheng Tian Jing Chen Hongxiang Gao Chenjie Xie Yuhua Shan Zhen Zhang Song Gu Min Xu

The proto-oncogene MYC can trigger the unfolded protein response (UPR). The double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK), one of three primary branches of the UPR, is a key regulator of autophagy, promoting tumorigenesis. Upon activation of PERK, there is an increase in phosphorylation of the eukaryotic initiation factor-2 alpha (eIF2α), which in turn, a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید